PD-1 blockade with the monoclonal antibody pembrolizumab (MK-3475) in patients with classical Hodgkin lymphoma after brentuximab vedotin failure: Preliminary results from a phase 1b study (KEYNOTE-013) Meeting Abstract
| Authors: | Moskowitz, C. H.; Ribrag, V.; Michot, J. M.; Martinelli, G.; Zinzani, P. L.; Gutierrez, M.; De Maeyer, G.; Jacob, A. G.; Giallella, K.; Anderson, J. W.; Derosier, M.; Wang, J.; Yang, Z. J.; Rubin, E.; Rose, S.; Shipp, M. A.; Armand, P. |
| Abstract Title: | PD-1 blockade with the monoclonal antibody pembrolizumab (MK-3475) in patients with classical Hodgkin lymphoma after brentuximab vedotin failure: Preliminary results from a phase 1b study (KEYNOTE-013) |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349233808074 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.290.290 |
| Notes: | Meeting Abstract: 290 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work